ECONOMYNEXT – Sri Lanka’s National Medicines Regulatory Authority (NMRA) has announced maximum retail prices (MRP) for 350 drugs, including common medications for blood pressure, and some cancer medications, effective immediately.
These include common medications for blood pressure, worm treatment and long term medications such as those for epilepsy, and even some cancer medications.
“Some patients don’t follow the prescribed medication dosage because the drugs are expensive; for example if a drug has been prescribed to be taken for a week they take it only for 3 days,” the NMRA’s Dr Ananda Wijewickrema told reporters.
“Our aim is that by ensuring a fair price, people will take them appropriately and maintain a good health condition.”
The MRP for Aspirin is now 5.85 per tablet (blister) and 4.50 per tablet (bulk).
The MRP for cancer medication Paclitaxel has been reduced from 42,000 rupees a vial to 26,332.29 a vial, Wijewickrema said.
Nimodipine, administered to prevent paralysis effects of a stroke, has been set at a MRP of 4,100 rupees from the previous 6,348.
Long term medication such as the anticonvulsant medication carbamazepine, available under the brand name Tegretol, is now 47.46 rupees from 58.32 rupees.
Maximum Retail Prices of Medicines
Pharmacies must display a price list, Wijewickrema said.
Officials asked the public to report instances where any individual or institution sells these medicines at a price higher than the approved MRP via email at complaints@nmra.gov.lk (Colombo/Nov17/2025)